METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
APPLICATION OF COST EFFECTIVENESS ANALYSES: FROM PREVENTION TO TREATMENT
H-2 ADHERENCE TO PREVENTIVE PRACTICES AND PROJECTED POPULATION IMPACT OF HEALTH SYSTEM INTERVENTIONS FOR CORONARY HEART DISEASE
N-4 TREAT, TEST, OR NEITHER? COST-EFFECTIVENESS OF CEREBROVASCULAR RESERVE IMAGING TO GUIDE TREATMENT OF CAROTID STENOSIS FOR STROKE PREVENTION
APPLICATION OF COST EFFECTIVENESS ANALYSES: FROM PREVENTION TO TREATMENT
H-2 ADHERENCE TO PREVENTIVE PRACTICES AND PROJECTED POPULATION IMPACT OF HEALTH SYSTEM INTERVENTIONS FOR CORONARY HEART DISEASE
N-4 TREAT, TEST, OR NEITHER? COST-EFFECTIVENESS OF CEREBROVASCULAR RESERVE IMAGING TO GUIDE TREATMENT OF CAROTID STENOSIS FOR STROKE PREVENTION
UNDERSTANDING THE PREFERENCE TO STAY WITH THE STATUS QUO
UNDERSTANDING DIFFERENCES BETWEEN BLACK AND WHITE PATIENTS' REACTIONS TO NEW TREATMENTS
PHYSICIANS' ROLES IN TREATMENT DECISION MAKING AMONG PROSTATE CANCER PATIENTS WITH RISING PSA LEVELS
NUMERACY AND THE USE AND MISUSE OF DENOMINATORS IN RISK PERCEPTIONS
UNDERSTANDING DIFFERENCES BETWEEN BLACK AND WHITE PATIENTS' REACTIONS TO NEW TREATMENTS
PHYSICIANS' ROLES IN TREATMENT DECISION MAKING AMONG PROSTATE CANCER PATIENTS WITH RISING PSA LEVELS
NUMERACY AND THE USE AND MISUSE OF DENOMINATORS IN RISK PERCEPTIONS